Instrument Inactif

Autres langues Bio-Path Holdings Inc Nasdaq

Actions

US09057N2018

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Bio-Path Holdings Provides Clinical Update and Expansion Plans	08/07
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress	14/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia At European Hematology Association Congress	14/06
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	05/06
Bio-Path Holdings, Inc. announced that it has received $4.000001 million in funding	05/06
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24	04/06
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	04/06
Bio-Path Holdings, Inc. announced that it expects to receive $4.000001 million in funding	04/06
Sector Update: Health Care Stocks Gain Late Afternoon	03/06
Top Midday Gainers	03/06
Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	03/06
Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	03/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting	03/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia At American Society of Clinical Oncology Annual Meeting	03/06
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress	24/05
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	23/05
Bio-Path: Q1 Earnings Snapshot	15/05
Bio-Path Holdings Reports First Quarter 2024 Financial Results	15/05
Bio-Path Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024	08/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bio-Path Holdings Inc Nasdaq

Actions

US09057N2018

Autres langues

Filtres